Targeting bone metastases in metastatic castration-resistant prostate cancer
Skeletal involvement in metastatic castrate-resistant prostate cancer (mCRPC) is common and results in significant morbidity and mortality. The interaction of prostate cancer with the bone microenvironment contributes to progression of cancer in the bone leading to skeletal-related events (SREs). St...
محفوظ في:
| المؤلف الرئيسي: | El-Amm, Joelle (author) |
|---|---|
| مؤلفون آخرون: | Aragon-Ching, Jeanny B. (author) |
| التنسيق: | article |
| منشور في: |
2016
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/6244 http://dx.doi.org/ 10.4137/CMO.S30751 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807885/ |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Bone-targeted therapies in metastatic castration-resistant prostate cancer
حسب: El-Amm, Joelle
منشور في: (2013) -
Metastatic castration-resistant prostate cancer
حسب: El-Amm, Joelle
منشور في: (2013) -
The changing landscape in the treatment of metastatic castration-resistant prostate cancer
حسب: El Amm, Joelle
منشور في: (2012) -
Impact of abiraterone on patient-related outcomes in metastatic castration-resistant prostate cancer
حسب: El-Amm, Joelle
منشور في: (2017) -
Enzalutamide for patients with metastatic castration-resistant prostate cancer
حسب: Ramadan, Wijdan H.
منشور في: (2015)